Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06222333

Breathing Exercise for Rib Fracture

Can Breathing Exercise Reduce Pulmonary Complications in Rib Fractures: Randomized Prospective Study

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
62 (estimated)
Sponsor
Kastamonu University · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

Respiratory physiotherapy is routinely performed after thoracic surgery operations to increase lung expansion and prevent pulmonary complications such as atelectasis and pneumonia. It is a controversial issue whether respiratory physiotherapy reduces pulmonary complications in rib fractures. In our study, patients with rib fractures will be divided into two groups. In the control group, standard treatment consisting of routine analgesic treatments will be applied. In the other group, respiratory physiotherapy will be applied with triflu for 8 hours a day. At the end of the study, pulmonary complications in both groups will be compared.

Detailed description

Patients between the ages of 18 and 100 who will apply to our hospital due to rib fractures between April 2024 and April 2025 will be evaluated. Patients who meet the inclusion criteria will be included in the study. Patients will be divided into two groups using randomization blocks. Patients in the control group will receive conservative treatment consisting of paracetamol and dexketoprofen. In the other group of patients, in addition to conservative treatment, triflow breathing exercise will be applied for 8 hours a day. Respiratory function test pain scores and pulmonary complications of patients in the two groups will be compared statistically.

Conditions

Interventions

TypeNameDescription
BEHAVIORALRespiratory physiotherapyIn this group of patients, in addition to routine analgesic treatment, triflow use and deep breathing training would be given by the physiotherapist. Patients in this group will do breathing exercises 8 hours a day, 10 times an hour.
DRUGConservative TreatmentPatients in the control group will receive conservative treatment consisting of paracetamol and dexketoprofen.

Timeline

Start date
2024-11-13
Primary completion
2025-04-01
Completion
2026-04-01
First posted
2024-01-24
Last updated
2024-11-14

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06222333. Inclusion in this directory is not an endorsement.